2017 Q3 Form 10-Q Financial Statement

#000114420417057905 Filed on November 13, 2017

View on sec.gov

Income Statement

Concept 2017 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $50.00K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $195.1K
YoY Change
Operating Profit -$240.1K
YoY Change
Interest Expense $440.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $195.7K
YoY Change
Income Tax $51.23K
% Of Pretax Income 26.18%
Net Earnings $144.4K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.01
COMMON SHARES
Basic Shares Outstanding 6.515M shares
Diluted Shares Outstanding 21.00M shares

Balance Sheet

Concept 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M
YoY Change
Cash & Equivalents $986.5K
Short-Term Investments
Other Short-Term Assets $200.0K
YoY Change
Inventory
Prepaid Expenses $234.5K
Receivables
Other Receivables
Total Short-Term Assets $1.200M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $235.0M
YoY Change
Total Long-Term Assets $235.1M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.200M
Total Long-Term Assets $235.1M
Total Assets $236.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $104.7K
YoY Change
Accrued Expenses $66.75K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $222.6K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $8.100M
YoY Change
Total Long-Term Liabilities $8.100M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $222.6K
Total Long-Term Liabilities $8.100M
Total Liabilities $8.273M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $143.6K
YoY Change
Common Stock $4.856M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M
YoY Change
Total Liabilities & Shareholders Equity $236.3M
YoY Change

Cashflow Statement

Concept 2017 Q3
OPERATING ACTIVITIES
Net Income $144.4K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$320.0K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$234.6M
YoY Change
Cash From Investing Activities -$234.6M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 235.9M
YoY Change
NET CHANGE
Cash From Operating Activities -320.0K
Cash From Investing Activities -234.6M
Cash From Financing Activities 235.9M
Net Change In Cash 970.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$320.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Industrea Acquisition Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001703956
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
104651 USD
dei Document Type
DocumentType
10-Q
CY2017Q3 us-gaap Assets
Assets
236256682 USD
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66751 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
222628 USD
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4855755 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
5000008 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
236256682 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
89651 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-319019 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
224403 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
235905490 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
986471 USD
CY2017Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
230000000 USD
CY2017Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
13300000 USD
CY2017Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
234600000 USD
CY2017Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.20
CY2017Q3 induu Miniumum Percentage Of Redeem Of Shares
MiniumumPercentageOfRedeemOfShares
0.15 pure
CY2017Q3 induu Percentage Of Redeem Of Public Shares
PercentageOfRedeemOfPublicShares
1 pure
CY2017Q3 us-gaap Interest Receivable
InterestReceivable
100000 USD
CY2017Q3 us-gaap Share Price
SharePrice
10.20
CY2017Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2017Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
12.00
CY2017Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
224403 USD
CY2017Q3 us-gaap Due To Officers Or Stockholders Current And Noncurrent
DueToOfficersOrStockholdersCurrentAndNoncurrent
50000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10000 USD
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
234456 USD
CY2017Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
235035755 USD
CY2017Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
51226 USD
CY2017Q3 induu Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
8050000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
8272628 USD
CY2017Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
222984046 USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
143564 USD
CY2017Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21861181 shares
CY2017Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.20
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Trading Symbol
TradingSymbol
INDUU
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
986471 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
195091 USD
us-gaap Operating Expenses
OperatingExpenses
195965 USD
CY2017Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
45000 USD
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
45000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-240091 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-240965 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
435755 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
435755 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
195664 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
194790 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51226 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51226 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
144438 USD
us-gaap Net Income Loss
NetIncomeLoss
143564 USD
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13954678 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6514940 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6161547 shares
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
51226 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
66751 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
234456 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
234600000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-234600000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
11100000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
224780490 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
224403 USD
induu Stock Issuance Costs
StockIssuanceCosts
15000 USD
induu Deferred Underwriting Commissions
DeferredUnderwritingCommissions
8050000 USD
us-gaap Stock Issued1
StockIssued1
222984046 USD
us-gaap Interest Expense
InterestExpense
100000 USD
CY2017Q3 induu Working Capital
WorkingCapital
1000000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Concentration of Credit Risk</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 15pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 15pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At September 30, 2017, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 15pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 15pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
13300000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
0 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 USD
induu Stock Issued During Period Value Issues In Initial Public Offering
StockIssuedDuringPeriodValueIssuesInInitialPublicOffering
216715490 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
11100000 USD
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
222984046 USD

Files In Submission

Name View Source Status
0001144204-17-057905-index-headers.html Edgar Link pending
0001144204-17-057905-index.html Edgar Link pending
0001144204-17-057905.txt Edgar Link pending
0001144204-17-057905-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
induu-20170930.xml Edgar Link completed
induu-20170930.xsd Edgar Link pending
induu-20170930_cal.xml Edgar Link unprocessable
induu-20170930_def.xml Edgar Link unprocessable
induu-20170930_lab.xml Edgar Link unprocessable
induu-20170930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv478961_10q.htm Edgar Link pending
tv478961_ex31-1.htm Edgar Link pending
tv478961_ex31-2.htm Edgar Link pending
tv478961_ex32-1.htm Edgar Link pending
tv478961_ex32-2.htm Edgar Link pending